Journal of Stem Cell Research & Therapy

Targeting TRIM5? in HIV cure strategies for the CRISPR-Cas9 era

Genome?edited adult stem cells: Next?generation advanced therapy medicinal products

The TRACE-Seq method tracks recombination alleles and identifies clonal reconstitution dynamics of gene targeted human hematopoietic stem cells

A practical guide to genome editing using targeted nuclease technologies

Single-cell assessment of transcriptome alterations induced by Scriptaid in early differentiated human haematopoietic progenitors during ex vivo expansion

Cell competition, the kinetics of thymopoiesis, and thymus cellularity are regulated by double-negative 2 to 3 early thymocytes

The importance of understanding and designing cellular therapy supply chains

Antiviral immunity and nucleic acid sensing in haematopoietic stem cell gene engineering

Recent advances in primary immunodeficiency: from molecular diagnosis to treatment

Therapeutic approaches to the use of the CRISPR / Cas genome editing system in hereditary diseases in humans and model animals

Therapeutic approaches to the use of the CRISPR / Cas genome editing system in hereditary diseases in humans and model animals

 Luigi NALDINI Lauréat du Prix Jeantet-Collen pour la médecine translationnelle 2019 L'Italien Luigi Naldini reçoit le Prix Jeantet-Collen pour la médecine …

Transdiferenciace somatických bun?k do hepatocyt? a klinicky relevatní editace genu Tight junction protein 2

CRISPR/Cas9 genome engineering in hematopoietic cells

Genome editing to model and reverse a prevalent mutation associated with myeloproliferative neoplasms

Advances in site-specific gene editing for primary immune deficiencies

Editing outside the body: ex vivo gene-modification for ?-hemoglobinopathy cellular therapy

CRISPR/Cas9 applications in gene therapy for primary immunodeficiency diseases

Gene editing for the treatment of primary immunodeficiency disease

Gene therapy for primary immunodeficiencies: up-to-date